Influence of immune signals on the hypothalamic-pituitary axis of the rodent

Frontiers in Neuroendocrinology

Volumn 16, Issue 2, 1995, Pages 151-182

  Rivier, Catherine ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028943167     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1995.1005     Document Type: Article

References (214)

1. Arai K-I, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Anna Rev Biochem 1990; 783-836.
2. Arimura A. Cytokines/hypothalamic-pituitary-adrenal axis interactions. Physiologist 1994; 37: A-38.
3. Axelrod J, Reisine TD. Stress hormones: Their interaction and regulation. Science 1984; 224: 452-459.
4. Ban E, Haour F, Lenstra R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 1992; 4: 48-54.
5. Ban E, Sarlieve L, Haour F. Interleukin-1 binding sites on astrocytes. Neuroscience 1993; 52: 725-733.
6. Banks W, Kastin A, Guttierrez E. Interleukin-la in blood has direct access to cortical brain cells. Neurosci Lett 1993; 163: 41-44.
7. Banks WA, Kasin AJ. The interleukin-lalpha, interleukin-lalpha, and interleukin-2 do not acutely disrupt the murine blood brain barrier, IntJ Pharmacol 1992; 14: 629-636.
8. Barbanel B, Gaillet S, Mekaouche M, Givalois L, Ixart G, Siaud P, Szafarczyk S, Malaval F, Assenmacher I. Complex catecholaminergic modulation of the stimulatory effect of interleu-kin-l 3 on the corticotropic axis. Brain Res 1993; 626: 31-36.
9. Bartfai T, Schultzberg M. Cytokines in neuronal cell types. Neurochem Int 1993; 212: 435-444.
10. Bauer J, Berkenbosch F, Van Dam A-M, Dijkstra CD. Demonstration of interleukin-If) in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol 1993; 48:13-22.
11. Beach JE, Smallridge RC, Kinzer CA, Bernton EW, Holaday JW, Fein HG. Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. Life Sci 1989; 44:1-7.
12. Beisel WR, Rapoport MI. Inter-relations between adrenocortical functions and infectious illness. N Engl J Med 1969; 280: 541-546.
13. Berkenbosch F, deGoeij DEC, DelRey A, Besedovsky HO. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 1989; 50: 570-576.
14. Bernardini R, Calogero AE, Mauceri G, Chrousos GP. Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner. Life Sci 1990; 47: 1601-1607.
15. Bernardini R, Mauceri G, Iurato MP, Chiarenza A, Lempereur L, Scapagnini U. Response of the hypothalamic-pituitary-adrenal axis to interleukin 1 in the aging rat. Prog NeuroEndo-crinlmmunol 1992; 5: 166-171.
16. Besedovsky H, DelRey A, Sorkin E, DaPrada M, Burri R, Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science 1983; 221: 564-566.
17. Besedovsky H, Sorkin E. Changes in blood hormone levels during the immune response. Proc Soc Exper Biol Med 1975; 150: 466-470.
18. Besedovsky HO, DelRey A. Immuno-neuroendocrine circuits: Integrative role of cytokines. Front Neuroendocrinol 1992; 13: 61-94.
19. Besedovsky HO, DelRey A, Klusman I, Furukawa H, Arditi GM, Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Ster Biochem Mol Biol 1991; 40: 613-618.
20. Besedovsky HO, Rey AD. Mechanism of virus-induced stimulation of the hypothalamus-pituitary-adrenal axis. J Ster Biochem 1989; 34: 235-239.
21. Brady LS, Lynn AB, Herkenham M, Gottesfeld Z. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 1994; 14: 4951-4964.
22. Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240: 321-322.
23. Bristow AF, Mosley K, Poole S. Interleukin-1 β production in vivo and in vitro in rats and mice measured using specific immunoradiometric assays. J Mol Endocrinol 1991; 7: 1-7.
24. Buckingham JC, Loxley HD, Taylor AD, Flower RJ. Cytokines, glucocorticoids and neuroendocrine function. Pharmacol Res 1994; 30: 35-42.
25. Burroughs M, Cabellos C, Prasad S, Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier: Does cell wall add to the effects of endotoxin in gram-negative meningitis? J Infect Dis 1992; 165: 82-5.
26. Busbridge NJ, Grossman AB. Stress and the single cytokine: Interleukin modulation of the pituitary-adrenal axis. Mol Cell Endocrinol 1991; 82: C209-C214.
27. Cambronero JC, Rivas FJ, Borrell J, Guaza C. Interleukin-1-beta induces pituitary adrenocor-ticotropin secretion: Evidence for glucocorticoid modulation. Neuroendocrinology 1992; 55: 648-654.
28. Cambronero JC, Rivas FJ, Borrell J, Guaza C. Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism. EurJPharmacol 1992; 219: 75-80.
29. Chan RKW, Brown ER, Ericsson A, Kovacs KJ, Sawchenko PE. A comparison of two immediate-early genes, c-fos and NGFI-fl, as markers for functional activation in stress-related neuroendocrine circuitry. J Neurosci 1993; 13: 5126-5138.
30. Chio SL, Sin YM. Changes in corticosterone levels under different degrees of acute inflammation in mice. Agents Act 1992; 36: 93-98.
31. Chover-Gonzalez AJ, Harbuz MS, Lightman SL. Effect of adrenalectomy and stress on interleukin-lfi-mediated activation of hypothalamic corticotropin-releasing factor mRNA. J Neuroimmunol 1993; 42: 155-160.
32. Chover-Gonzalez AJ, Lightman SL, Harbuz MS. An investigation of the effects of interleukin-1β on plasma arginine vasopressin in the rat: Role of adrenal steroids. J Endocrinol 1994; 142:361-366.
33. Chowdrey H, Larsen P, Harbuz M, Jessop D, Aguilera G, Lightman S. Arginine Vasopressin as the Primary Activator of the HPA Axis during Adjuvant Arthritis. First World Congress on Stress, Bethesda, MD. p. 44, 1994.
34. Chuluyan HE, Saphier D, Rohn WM, Dunn AJ. Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. Neuroendocrinology 1992; 56: 106-111.
35. Cunningham ET, DeSouza EB. Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today 1993; 14: 161-176.
36. Derijk RH, vanRooijen N, Berkenbosch F. The role of macrophages in the hypothalamic-pituitary-adrenal activation in response to endotoxin (LPS). Res Immunol 1992; 143: 224-229.
37. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652.
38. Doucet JP, Squinto SP, Bazan NG. Fos-jun and the primary genomic response in the nervous system. Mol Neurobiol 1990; 27-55.
39. Dugue B, Leppanen EA, Teppo AM, Fyhrquist F, Grasbeck R. Effects of psychological stress on plasma interleukin-1-beta and interleukin-6-beta, C-reactive protein, tumour necrosis factor-alpha, anti-diuretic hormone and serum cortisol. Scand J Clin Lab Invest 1993; 53: 555-561.
40. Dunn A, Vickers S. Neurochemical and neuroendocrine responses of Newcastle disease virus administration in mice. Brain Res 1994; 645: 103-112.
41. Dunn AJ. Interleukin-1 as a stimulator of hormone secretion. Prog NeuroEndocrinlmmunol 1990;3:26-34.
42. Dunn AJ. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 1988; 43: 429-435.
43. Dunn AJ, Chuluyan HE. The role of cyclo-oxygtenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: Dependence on the route of injection. Life Sci 1992; 51: 219-225.
44. Dunn AJ, Powell ML, Meitin C, Small PA Jr. Virus infection as a stressor: Influenza virus elevates plasma concentration of corticosterone, and brain concentrations of MHPG and tryptophan. Physiol Behau 1989; 45: 591-594.
45. Ebisui O, Fukata J, Murakami N, Kobayashi H, Segawa H, Muro S, Hanaoka I, Naito Y, Masui Y, Ohmoto Y, Imura H, Nakao K. Effect of IL-1 receptor antagonist and antiserum to TNF-a on LPS-induced plasma ACTH and corticosterone rise in rats. Am J Physiol 1994; 266: E986-E992.
46. Eisenberg SP, Evans RJ, Brewer MT, Verderber E, Arend WP, Hannum CH, Thompson RC. Cloning, sequencing, and expression of the cDNA for the human interleukin 1 receptor antagonist, II-Ira. Mol Cell Endocrinol 1990; 10: 293-298.
47. Elmquist JK, Ackermann MR, Register KB, Rimler RB, Ross LR, Jacobson CD. Induction of Fos-like immunoreactivity in the rat brain following Pasteurella multocida endotoxin administration. Endocrinology 1993; 133: 3054-3057.
48. Ericsson A, Kovacs KJ, Sawchenko PE. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 1994; 14: 897-913.
49. Ericsson A, Sawchenko PE. c-fos-Based functional mapping of central pathways subserving the effects of interleukin-1 on the hypothalamo-pituitaiy-adrenal axis. In: DeSouza EB, Ed. Methods in Neuroscience. New York: Academic Press, 1993: 155-172.
50. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chau dry IH. The complex pattern of cytokines in sepsis-association between prostaglandins, cachectin, and interleukins. Ann Surg 1991; 214: 141-148.
51. Fagarasan MO, Eskay R, Axelrod J. Interleukin 1 potentiates the secretion of p-endorphin induced by secretagogues in a mouse pituitary cell line (AtT-20). Proc Natl Acad Sci USA 1989; 86: 2070-2073.
52. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, Cerami A. Antibodies to cachectin/tumor necrosis factor reduce interleukin lp and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989; 170: 1627-1633.
53. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. EurJImmunol 1989; 19: 689-694.
54. Freidin M, Bennett MVL, Kessler JA. Cultured sympathetic neurons synthesize and release the cytokine interleukin lp. Proc Natl Acad Sci USA 1992; 89: 10440-10443.
55. Fukata J, Imura H, Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J Endocrinol Invest 1993; 16:141-155.
56. Gatti S, Bartfai T. Induction of tumor necrosis factor-a mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res 1993; 624: 291-294.
57. Gisslinger H, Svoboda T, Clodi M, Gilly B, Ludwig H, Havelec L, Luger A. Interferon-a stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 1993; 57: 489-495.
58. Givalois L, Dornand J, Mekaouche M, Solier M, Bristow A, Ixart G, Siaud P, Assenmacher I, Barbanel G. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. AmJ Physiol 1994; 267: R164-R170.
59. Gottschall PE, Tatsuno I, Arimura A. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res 1994; 637: 197-203.
60. Grossman A. Editorial: NO news is good news. Endocrinology 1994; 134: 1003-1005.
61. Hagan P, Poole S, Bristow AF. Endotoxin-stimulated production of rat hypothalamic interleukin-l[i in vivo and in vitro, measured by specific immunoradiometric assay. J Mol Endocrinol 1993;11:31-36.
62. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336-340.
63. Harbuz MS, Lightman SL. Stress and the hypothalamo-pituitary-adrenal axis: Acute, chronic and immunological activation. J Endocrinol 1992; 134: 327-339.
64. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology 1992; 130: 1394-1400.
65. Hedge GA. The effects of prostaglandins on ACTH secretion. Endocrinology 1972; 91: 925-933.
66. Holt I, Cooper R, Hopkins S. Relationship between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritic patients. Eur J Clin Invest 1991; 21: 479-484.
67. Jessop DS, Lightman SL. Priming of the anterior pituitary with corticotropin-releasing hormone in vitro does not facilitate an ACTH response to interleukin-1 p. Immunol Lett 1994; 41: 225-228.
68. Kabiersch A, DelRey A, Honegger CG, Besedovsky HO. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 1988; 2: 267-274.
69. Kasting NW. Indomethacin, an antipyretic drug, prevents the endotoxin-induced and potentiates the hemorrhage-induced oxytocin release into the plasma of the male rat. Neuroendocrinology 1986;42:285-288.
70. Kasting NW, Mazurek MF, Martin JB. Endotoxin increases vasopressin release independently of known physiological stimuli. Am J Physiol 1985; 248: 420-424.
71. Katsuura G, Arimura A, Koves K, Gottschall PE. Involvement of organum vasculosum of lamina Lerminalis and preoptic area in interleukin lp-induced ACTH release. Am J Physiol 1990; 258: 163-171.
72. Katsuura G, Gottschall PE, Dahl RR, Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology 1988; 122: 1773-1779.
73. Katsuura G, Gottschall PE, Dahl RR, Arimura A. Interleukin-1 beta increases prostaglandin E2 in rat astrocyte cultures: Modulatory effect of neuropeptides. Endocrinology 1989; 124: 3125-3127.
74. Kehrer P, Turnill D, Dayer J-M, Muller AF, Gaillard RC. Human recombinant interleukin-lbeta and-alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner. Neuroendocrinology 1988; 48: 160-166.
75. Kimelberg A, Aschner M. Astrocytes and their functions, past and present. In: Lancaster F, Ed. Alcohol and Glial Cells. Bethesda, MD: National Institute of Health, 1994: 1-40.
76. Klir JJ, McClellan JL, Kluger MJ. Interleukin-lp causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am J Physiol 1994; 266: R1845-R1848.
77. Kobayashi H, Wada M, Uemura H. The hypothalamic median eminence as a neuroendocrine organ. Med J Osaka Univ 1972; 23: 43-49.
78. Koenig JI. Presence of cytokines in the hypothalamic-pituitary axis. Prog NeuroEndocrinlm-munol 1991; 4:143-153.
79. Koenig JI, Snow K, Clark BD, Toni R, Cannon JG, Shaw AR, Dinarello CA, Reichlin S, Lee SL, Lechan RM. Intrinsic pituitary interleukin-lp is induced by bacterial lipopolysaccharide. Endocrinology 1990; 126: 3053-3058.
80. Komaki G, Arimura A, Koves K. Effect of intravenous injection of IL-lp on PGE2 levels in several brain areas as determined by microdialysis. Am J Physiol 1992; 262: 246-251.
81. Komaki G, Gottschall PE, Somogyvari-Vigh A, Tatsuno I, Yatohgo T, Arimura A. Rapid increase in plasma IL-6 after hemorrhage, and posthemorrhage reduction of the IL-6 response to LPS, in conscious rats: Interrelation with plasma corticosterone levels. Neuroimmunomodu-lation 1994; 1: 127-134.
82. Laye S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol Brain Res 1994; 27:157-162.
83. Lee S, Rivier C. Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-lp systemically or into the brain ventricles. JNeuroendocrinol 1994; 6: 217-224.
84. Levine S, Berkenbosch F, Suchecki D, Tilders FJH. Pituitary-adrenal and interleukin-6 responses to recombinant interleukin-1 in neonatal rats. Psychoneuroendocrinology 1994; 19: 143-153.
85. Levine S, Huchton DM, Weiner SG, Rosenfeld P. Time course of the effect of maternal' deprivation on the hypothalamic-pituitary-adrenal axis in the infant rat. Dev Psychobiol 1992; 24: 547-558.
86. Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989; 86: 6348-6352.
87. Lightman S. Chronic Inflammation and the HPA Axis. 1st World Congress on Stress, Bethesda, MD. p. 59, 1994.
88. Liposits Z, Pauli WK, Setalo G, Vigh S. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. Histochemistry 1985; 83: 5-16.
89. Long N, Otterness A, Kunkel S, Vander A, Kluger M. Roles of interleukin ip and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 1990; 259: 724-728.
90. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: A physiologic messenger. Ann Intern Med 1994; 120:227-237.
91. Madison DV. Commentary: Pass the nitric oxide. Proc Natl Acad Sci USA 1993; 90: 4329-4331.
92. Matta SG, Singh J, Newton R, Sharp BM. The adrenocorticotropin response to interleukin-lp instilled into the rat median eminence depends on the local release of catecholamines. Endocrinology 1990; 127: 2175-2182.
93. McCoy JG, Matta SG, Sharp BM. Prostaglandins mediate the ACTH response to interleukin-1-beta instilled into the hypothalamic median eminence. Neuroendocrinology 1994; 60: 426-435.
94. Membreno L, Irony I, Dere W, Klein R, Bilglieri E. Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocr Metab 1987; 65: 482-487.
95. MohanKumar PS, Quadri SK. Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci 1993; 52:1961-1967.
96. Mohankumar PS, Thyagarajan S, Quadri SK. Interleukin-1 simulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci 1991; 48: 925-930.
97. Molenaar G, Berkenbosch F, Dam AMV, Lugard C. Distribution of interleukin ip immunore-activity within the porcine hypothalamus. Brain Res 1993; 608: 169-174.
98. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
99. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: Involvement of the inductible proto-oncogenes fos andjun. Annu Rev Neurosci 1991; 14: 421-451.
100. Morimoto A, Murakami N, Nakamori T, Sakata Y, Watanabe T. Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1. J Physiol 1989; 411: 245-256.
101. Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 1993; 133:2574-2578.
102. Naito Y, Fukata J, Masui Y, Hirai Y, Murakami N, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H. Interleukin-1 fi analogues with markedly reduced pyrogenic activity can stimulate secretion of adrenocorticotropic hormone in rats. Biochem Biophys Res Commun 1990; 167: 103-109.
103. Naito Y, Fukata J, Shindo K, Ebisui O, Murakami N, Tominaga T, Nakai Y, Mori K, Kastingh NW, Imura H. Effects of interleukins on plasma arginine vasopressin and oxytocin levels in conscious, freely moving rats. Biochem Biophys Res Commun 1991; 174: 1189-1195.
104. Naito Y, Fukata J, Tominaga T, Masui Y, Hirai Y, Murakami N, Tamai S, Mori K, Imura H. Adrenocorticotropic hormone-releasing activities of interleukins in a homologous in vivo system. Biochem Biophys Res Commun 1989; 164: 1262-1267.
105. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988; 155:1459-1463.
106. Navarra P, Pozzoli G, Brunetti L, Ragazzoni E, Besser M, Grossman A. Interleukin-lp and interleukin-6 specifically increase the release of prostaglandin E2 from rat hypothalamic explants in vitro. Neuroendocrinology 1992; 56: 61-68.
107. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Interleukins-1 and-6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991; 128: 37-45.
108. Negro-Vilar A. The median eminence as a model to study presynaptic regulation of neural peptide release. Peptides 1982; 3: 305-310.
109. Nistico G. Communications among central nervous system, neuroendocrine and immune systems: Interleukin-2. Prog Neurobiol 1993; 40: 463-475.
110. North J, Situnayake RD, Tikly M, Cremona A, Nicholl J, Kumararatne DS, Nuki G. Interleukin 1 beta, hand and foot bone mineral content and the development of joint erosions in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 543-546.
111. O'Grady MP, Hall NRS, Menzies RA. Interleukin-lb stimulates adrenocorticotropin and corticosterone release in 10-day-old rat pups. Psychoneuroendocrinology 1993; 18: 241-247.
112. Ojeda S. The neurobiology of mammalian puberty: Has the contribution of glial cells been underestimated? J NIH Res 1994; 6: 51-56.
113. Parkes D, Rivest S, Lee S, Rivier C, Vale W. Corticotropin-releasing factor activates c-fos, NGFI-p, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. Mol Endocrinol 1994; 7: 1357-1367.
114. Parsadaniantz SM, Lenoir V, Terlain B, Kerdelhue B. Lack of effect of interleukins la and lp, during in vitro perifusion, on anterior pituitary release of adrenocorticotropic hormone and p endorphin in the male rat. J Neurosci Res 1993; 34: 315-323.
115. Payne L, Weignet D, Blalock J. Induction of pituitary sensitivity to interleukin-1: A new function for corticotropin-releasing hormone. Biochem Biophys Res Commun 1994; 198: 480-484.
116. Perlstein RS, Mougey EH, Jackson WE, Neta R. Interleukin-1 and interleukin-6 act synergis-tically to stimulate the release of adrenocorticotropic hormone in vivo. Lymph Cyt Res 1991; 10:141-146.
117. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R. Synergistic roles of interleu-kin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993; 132: 946-952.
118. Perry H, Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci 1988; 11:273-277.
119. Piani D, Constam D, Frei K, Fontana A. Macrophages in the brain: Friends or enemies? NIPS 1994; 9: 80-84.
120. Plotsky P, Cunningham ETJ, Widmaier EP. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrine Rev 1989; 10: 437-458.
121. Quan N, Sundar SK, Weiss JM. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol 1994; 49: 125-135.
122. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993; 329: 1246-1253.
123. Reimers J, Wogensen L, Welinder B, Hejnaes K, Poulsen S, Nilsson P, Nerup J. The pharmacokinetics, distribution and degradation of human recombinant interleukin 1-p in normal rats. J Immunol 1991; 34: 597-617.
124. Rettori V, Belova N, Dees W, Nyberg C, Gimeno M, McCann S. Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proc Natl Acad Sci USA 1993; 90: 10130-10134.
125. Rey AD. Cytokines and hormone interactions. Physiologist 1994; 37: A-2.
126. Rho J-H, Swanson L. Neuroendocrine CRF motoneurons: intrahypothalamic axon terminals shown with a new retrograde-Lucifer-immuno method. Brain Res 1987; 436: 143-147.
127. Rivest S, Rivier C. Stress and interleukin-1 β-induced activation of c-fos, NGFI-p and CRF gene expression in the hypothalamic PVN: Comparison between Sprague-Dawley, Fisher-344 and Lewis rats. JNeuroendocrinol 1994; 6: 101-117.
128. Rivest S, Torres G, Rivier C. Differential effects of central and peripheral injection of interleukin-ip on brain c-fos expression and neuroendocrine functions. Brain Res 1992; 587: 13-23.
129. Rivier C. Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Ann New York Acad Sci. 1993; 697: 97-105.
130. Rivier C. Effects of cytokines on endocrine function in the rat. In: Grossman CJ, Ed. Hormones and Immunity-Bilateral Communication between the Endocrine and Immune Systems. New York: Springer-Verlag, 1993: 183-196.
131. Rivier C. Involvement of endogenous corticotropin-releasing factor (CRF) in modulating ACTH and LH secretion function during exposure to stress, alcohol or cocaine in the rat. In: Zinder O, Bresnitz S, Ed. Molecular Biology of Stress. New York, A.R. Liss, 1989: 31-47.
132. Rivier C. Neuroendocrine effects of cytokines in the rat. Rev Neurosci 1993; 4: 223-238.
133. Rivier C. Stimulatory effect of interleukin-1β on the hypothalamic-pituitary-adrenal axis of the rat: Influence of age, gender and circulating sex steroids. J Endocrinol 1994; 140: 365-372.
134. Rivier C, Chizzonite R, Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 1989; 125: 2800-2805.
135. Rivier C, Rivest S. Effect of stress on the activity of hypothalamic-pituitary-gonadal axis in the rat. Biol Reprod 1991; 45: 523-532.
136. Rivier C, Shen G. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-lp, vasopressin and oxytocin. J Neurosci 1994; 14:1985-1993.
137. Rivier C, Vale W. Effects of CRF, neurohypophysial peptides and catecholamines on pituitary function. Fed Proc 1985; 44: 189-195.
138. Rivier C, Vale W. Interaction of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on ACTH secretion in vivo. Endocrinology 1983; 113: 939-942.
139. Rivier C, Vale W. Stimulatory effect of interleukin-1 on ACTH secretion in the rat: Is it modulated by prostaglandins? Endocrinology 1991; 129: 384-388.
140. Rivier C, Vale W, Brown M. In the rat, interleukin-la and-P stimulate adenocorticotropin and catecholamine release. Endocrinology 1989; 125: 3096-3102.
141. Roth J, Conn CA, Kluger MJ, Zeisberger E. Kinetics of systemic and intrahypothalamic IL-6 and tumor necrosis factor during endotoxin fever in guinea pigs. Am J Physiol 1993; 265: R653-658.
142. Rothwell NJ. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci 1991;12:430-436.
143. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, Hisano S, Ogawa M. Elevation of circulating interleukin 6 after surgery: Factors influencing the serum level. Cytokine 1994; 6: 181-186.
144. Saphier D, Ovadia H. Selective facilitation of putative corticotropin-releasing factor-secreting neurons by interleukin-1. Neurosci Lett 1990; 114: 283-288.
145. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522-524.
146. Sapolsky RM, Krey LC, McEwen BS. The adrenocortical axis in the aged rat: Impaired sensitivity to both fast and delayed feedback inhibition. Neurobiol Aging 1986; 7: 331-335.
147. Sapolsky RM, Meaney MJ, Maturation of the adrenocortical stress response: Neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 1986; 11: 65-76.
148. Sarlis N J, Chowdrey HS, Stephanou AK, Lightman SL. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 1992; 130:1775-1779.
149. Sarlis NJ, Stephanou A, Knight RA, Lightman SL, Chowdrey HS. Effects of glucocorticoids and chronic inflammatory stress upon anterior pituitary interleukin-6 mRNA expression in the rat. BrJ Rheumatol 1993; 32: 653-657.
150. Sawchenko PE, Imaki T, Vale W. Colocalization of neuroactive substances in the endocrine hypothalamus. In: Chadwick DJ, Marsh J, Eds. Functional Neuroanatomy of the Neuroendocrine Hypothalamus. Chichester: Wiley, 1992: 16-42.
151. Schmidt E, Janszen A, Binnenkade R, Persons J, Wouterlood F, Tilders F. Long-term changes in peptide make-up of hypothalamic CRH neurons after single administration of interleukin-lp. In: Gerendai I, Halasz B, Eds. Proc. of 3rd Inti Cong Neuroendocrinal. Basel: Karger, 1994: 45.
152. Schobitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 1994; 44: 397-432.
153. Schobitz B, Holsboer F, de Kloet ER. Cytokines in the healthy and diseased brain. NIPS 1994; 9:138-142.
154. Schoebitz B, van den Dobbelsteen M, Holsboer F, Subanto W, de Kloet ER. Regulation of interleukin 6 gene expression in rat. Endocrinology 1993; 132: 1569-1576.
155. Schotanus K, Tilders F, Berkenbosch F. Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats. Endocrinology 1993; 133: 2461-2468.
156. Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-a and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989; 53: 488-498.
157. Shankar V, Kao M, Hamir AN, Sheng H, Koprowski H, Dietzschold B. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with borna disease virus. J Virol 1992; 66: 992-998.
158. Shanks N, McCormick CM, Meaney MJ. Sex differences in hypothalamic-pituitary-adrenal responding to endotoxin challenge in the neonate: Reversal by gonadectomy. Dev Brain Res 1994;79: 260-266.
159. Shanks N, Meaney MJ. Hypothalamic-pituitary-adrenal activation following endotoxin administration in the developing rat: A CRH-mediated effect. J Neuroendocrinol 1994; 6: 375-383.
160. Sharief MK, Ciardi M, Thompson EJ. Blood-brain barrier damage in patients with bacterial meningitis: Association with tumor nectosis factor-a but not interleukin-1β. J Infect Dis 1992; 166: 350-358.
161. Sharp BM, Matta SG. Prostaglandins mediate the adrenocorticotropin response to tumor necrosis factor in rats. Endocrinology 1993; 132: 269-274.
162. Sharp BM, Matta SG, Peterson PK, Newton R, Chao C, McAllen K. Tumor necrosis factor-a is a potent ACTH secretagogue: Comparison to interleukin-lp. Endocrinology 1989; 124: 3131-3133.
163. Shek PN, Sabiston BH. Neuroendocrine regulation of immune processes: Change in circulating corticosterone levels induced by the primary antibody response in mice. Int J Immunophar-macol 1983; 5: 23-33.
164. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M. Interleukin-lp augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 1993; 13: 3574-3581.
165. Shioda S, Nakai Y, Kitazawa S, Sunayama H. Immunoeytochemical observations of corticotro-pin-releasing-factor-containing neurons in the rat hypothalamus with special reference to neuronal communication. ActaAnat 1985; 124: 58-64.
166. Sibbald WJ, Short A, Cohen MP, Wilson RF. Variations in adrenocortical responsiveness during severe bacterial infections. Ann Surg 1977; 186: 29-33.
167. Silverman AJ, Hou-Yu A, Chen WP. Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology 1989; 49: 291-299.
168. Smith EM, Meyer WJ, Blalock JE. Virus-induced corticosterone in hypophysectomized mice: A possible lymphoid adrenal axis. Science 1982; 218: 1311-1313.
169. Smith T, Hewson AK, Quarrie L, Leonard JP, Cuzner ML. Hypothalamic PGE2 and cAMP production and adrenocortical activation following intraperitoneal endotoxin injection: In vivo microdialysis studies in Lewis and Fischer rats. Neuroendocrinology 1994; 59: 396-405.
170. Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Amer 1992; 266: 68-77.
171. Spangelo BL, DeHoll PD, Kalabay L, Bond BR, Arnaud P. Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: Effects of lipopolysaccharide and interleukin-lp. Endocrinology 1994; 135: 556-563.
172. Spangelo BL, Jarvis WD, Judd AM, MacLeod RM. Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: Evidence for an eicosanoid-dependent mechanism. Endocrinology 1991; 129: 2886-2894.
173. Spangelo BL, MacLeod RM. Regulation of the acute phase response and neuroendocrine function by interleukin 6. Prog NeuroEndocrinlmmunol 1990; 3: 167-175.
174. Spangelo BL, MacLeod RM, Isakson PC. Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology 1990; 126: 582-586.
175. Spinedi E, Hadid R, Daneva T, Gaillard RC. Cytokines stimulate the CRH but not the vasopressin neuronal system: Evidence for a median eminence site of interleukin-6 action. Neuroendocrinology 1992; 45: 46-53.
176. Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC. Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: Evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 1992; 131: 2430-2436.
177. Stenberg VI, Bouley MG, Katz BM, Lee KJ, Parmar SS. Negative endocrine control system for inflammation in rats. Agents Act 1990; 29: 189-195.
178. Stephanou A, Sarlis NJ, Knight RA, Lightman SL, Chowdrey HS. Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary pro-opiomelanocortin, growth hormone and prolactin mRNAs during adjuvant-induced arthritis in the rat. J Mol Endocrinol 1992; 9: 273-281.
179. Stepien H, Zerek-Meten G, Mucha S, Winczyk K, Fryczak J. Interleukin-lp stimulates cell proliferation in the intermediate lobe of the rat pituitary gland. J Endocrinol 1994; 140: 337-341.
180. Sternberg EM. The stress response and the regulation of inflammatory disease. Ann Int Med 1992; 117: 854-866.
181. Suda T, Tozawa F, Ushiyama T, Sumitomo T, Yamada M, Demura H. Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 1990; 126:1223-1228.
182. Suda T, Tozawa F, Ushiyama T, Tomori N, Sumitomo T, Nakagami Y, Yamada M, Demura H, Shizume K. Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleukin-1 on proopiomelanocortin gene expression in rat anterior pituitary cells. Endocrinology 1989; 124:1444-1449.
183. Sugita T, Furukawa O, Ueno M, Murakami T, Takata I, Tosa T. Enhanced expression of interleukin 6 in rat and murine arthritis models. Int JImmunopharmacol 1993; 15: 469-476.
184. Swanson LW. The hypothalamus. In: Bjorklund A, Hokfelt P, Swanson LW, Eds. Handbook of Chemical Neuroanatomy. Amsterdam: Elsevier, 1987:1-124.
185. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. J Neuroimmunol 1993; 42: 177-186.
186. Terao A, Oikawa M, Saito M. Cytokine-induced change in hypothalamic norepinephrine turnover: Involvement of corticotropin-releasing hormone and prostaglandins. Brain Res 1993; 622:257-261.
187. Tilders FJH, DeRijk RH, Van Dam A-M, Vincent VAM, Schotanus K, Persoons JHA. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals. Psychoneuroendocrinology 1994; 19: 209-232.
188. Torre D, Zeroli C, Giola M, Ferrario G, Fiori GP, Bonetta G, Tambini R. Serum levels of interleukin-la, interleukin-lji, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994; 18: 194-198.
189. Trentham D, Towes S, Kang A. Autoimmunity to type II collage: An experimental model of arthritis. J Exp Med 1977; 146: 857-868.
190. Turnbull AV, Dow RC, Hopkins SJ, White A, Fink G, Rothwell NJ. Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat. Psychoneuroendocrinology 1994; 19: 165-178.
191. Uehara A, Gillis S, Arimura A. Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture. Neuroendocrinology 1987; 45: 343-347.
192. Uehara A, Gottschall PE, Dahl RR, Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 1987; 121:1580-1582.
193. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C. Effects of synthetic ovine CRF, glucocorticoids, catecholamines, neurohypophysial peptides and other substances on cultured corticotropic cells. Endocrinology 1983; 113: 1121-1131.
194. VanDam A-M, Brouns M, Louisse S, Berkenbosch F. Appearance of inlerleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: A pathway for the induction of non-specific symptoms of sickness? Brain Res 1992; 588: 291-296.
195. VanDam A-M, Brouns M, Man-A-Hing W, Berkenbosch F. Immunocytochemical detection of prostglandin E2 in microvasculature and in neurons of rat brain after administration of bacterial endotoxin. Brain Res 1993; 613: 331-336.
196. Vankelecom H, An dries M, Billiau A, Denef C. Evidence that folliculo-stellate cells mediate the inhibitory effect of interferon-7 on hormone secretion in rat anterior pituitary cell cultures. Endocrinology 1992; 130: 3537-3546.
197. Veening JG, van der Meer MJM, Joosten H, Hermus ARMM, Rijnkels CEM, Geeraedts LM, Sweep CGJ. Intravenous administration of interleukin-lp induces fos-like immunoreactivity in corticotropin-releasing hormone neurons in the paraventricular hypothalamic nucleus of the rat. J Chem Neuroanat 1993; 6: 391-397.
198. Waksman BH, Pearson CM, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. J Immunol 1960; 85: 403-417.
199. Wan W, Janz L, Vriend CY, Sorensen CM, Greenberg AH, Nance DM. Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res Bull 1993; 32: 581-587.
200. Wan WH, Wetmore L, Sorensen CM, Greenberg AH, Nance DM. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull 1994;34:7-14.
201. Watanabe T, Morimoto A, Murakami N. ACTH response in rats during biphasic fever induced by interleukin-1. Am J Physiol 1991; 261: 1104-1108.
202. Watanabe T, Morimoto A, Tan N, Makisumi T, Shimada S, Nakamori T, Murakami N. ACTH response induced in capsaicin-desensitized rats by intravenous injection of interleukin-1 or prostaglandin E. J Physiol 1994; 475: 139-145.
203. Watanobe H, Sasaki S, Takebe K. Effects of intravenous administration of interleukin-1β on the release of prostaglandin E2j corticotropin-releasing factor and arginine vasopressin in several hypothalamic areas of freely moving rats: Estimation by push-pull perfusion. Neuroendocrinology 1994; 60 (Suppl. 1): 43.
204. Watanobe H, Takebe K. Intrahypothalamic perfusion with interleukin-1-beta stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: A comparative perfusion of the paraventricular nucleus and the median eminence. Neuroendocrinology 1993; 57: 593-599.
205. Weidenfeld J, Abramsky O, Ovadia H. Evidence for the involvement of the central adrenergic system in interleukin 1-induced adrenocortical response. Neuropharmacology 1989; 28: 1411-1414.
206. Weidenfeld J, Amir I, Shohami E. Role of glucocorticoids in the regulation of brain prostaglandin biosynthesis under basal conditions and in response to endotoxin. Endocrinology 1993; 132:941-945.
207. Whitnall MH, Perlstein RS, Mougey EH, Neta R. Effects of interleukin-1 on the stress-responsive and-nonresponsive subtypes of corticotropin-releasing hormone neurosecretory axons. Endocrinology 1992; 131: 37-44.
208. Wilder RL, Allen JB, Hansen C. Thymus-dependent and -independent regulation of la antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis. J Clin Invest 1987; 79:1160-1171.
209. Wispelwey B, Lesse AJ, Hansen EJ, Scheld WM. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest 1988; 82: 1339-1346.
210. Witek-Janusek L. Pituitary-adrenal response to bacterial endotoxin in developing rats. Am J Physiol 1988; 255: 525-530.
211. Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A, Cuzner ML. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production. J Neuroimmunol 1991;33:227-236.
212. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH. Cytokine-specific central monoamine alterations induced by interleukin-1,-2 and-6. Brain Res 1994; 643: 40-49.
213. Zanetti G, Heumann D, Gerain J, Kohler J, Abbet P, Barras C, Lucas R, Clauser M-P, Baumgartner J-D. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J Immunol 1994; 148:1890-1897.
214. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993; 133: 2523-2530.